Psychopharmacological Drugs Advisory Committee Meeting
February 14, 2001 NDA 21-253 Intramuscular Olanzapine for the Rapid Control of Agitation Eli Lilly and Company Indianapolis, IN
Next slide
Back to first slide
View graphic version